asparagine has been researched along with Urinary Tract Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouckaert, J; De Greve, H; Garofalo, C; Hernalsteens, JP; Hultgren, S; Nguyen, H; Oscarson, S; Slättegård, R; Van Gerven, N; Wellens, A; Wyns, L | 1 |
| Deguchi, T; Kawada, Y; Kawamura, T; Nakano, M; Nishino, Y; Ozeki, S; Yasuda, M | 1 |
2 other study(ies) available for asparagine and Urinary Tract Infections
| Article | Year |
|---|---|
Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complex.
Topics: Adhesins, Escherichia coli; Animals; Anti-Bacterial Agents; Asparagine; Bacterial Adhesion; Biofilms; Cell Line; Crystallography, X-Ray; Cystitis; Disaccharides; Disease Models, Animal; Escherichia coli; Fimbriae Proteins; Fimbriae, Bacterial; Glycosylation; Humans; Intracellular Space; Mannosides; Mice; Oligosaccharides; Protein Structure, Tertiary; Receptors, Cell Surface; Substrate Specificity; Urinary Tract Infections | 2008 |
Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.
Topics: Anti-Infective Agents; Asparagine; Ciprofloxacin; DNA Gyrase; DNA Topoisomerases, Type II; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Humans; Incidence; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Serine; Urinary Tract Infections | 1997 |